Home » EMA: US FDA Cooperation Spurred Inspections Activity in 2010
EMA: US FDA Cooperation Spurred Inspections Activity in 2010
November 17, 2010
The European Medicines Agency (EMA) received 75 percent more requests for good clinical practice and pharmacovigilance inspections than anticipated for the first half of 2010, in part due to better information sharing with the U.S. Food and Drug Administration, the EMA says in a mid-year report.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor